Federal Register of Legislation - Australian Government

Primary content

PB 61 of 2010 Specifications as made
This Specification amends the National Health Act (Pharmaceutical Benefits - Early Supply) - specification under subsection 84AAA(2) Instrument 2009 (No. PB 30 of 2009) and determines pharmaceutical benefits that can be resupplied inside 20 days on the one prescription.
Administered by: Health
Registered 22 Jun 2010
Tabling HistoryDate
Tabled HR23-Jun-2010
Tabled Senate23-Jun-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 61 of 2010

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment July 2010 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated          3 June 2010

 

FELICITY MCNEILL

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment July 2010 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as “No. PB 61 of 2010”.


 

2          Commencement

 

This Instrument commences on 1 July 2010.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 


Schedule 1        Amendments

[1]                                  Schedule 1, item dealing with Esomeprazole

insert in the columns in the order indicated:

 

 

Tablet (enteric coated) 40 mg (as magnesium trihydrate)

Oral

30

5

 

 

[2]                                  Schedule 1, item dealing with Oestradiol

omit from the columns in the order indicated:

 

 

Transdermal patches 4 mg, 8

Transdermal

1

5

 

 

[3]                                  Schedule 1, item dealing with Oestradiol and Oestradiol with Norethisterone

omit from the columns in the order indicated:

 

 

Pack containing 4 transdermal patches oestradiol 4 mg and 4 transdermal patches oestradiol 10 mg with norethisterone acetate 30 mg

Transdermal

1

5

 

 

[4]                                  Schedule 1, item dealing with Rosuvastatin

insert in the columns in the order indicated:

 

 

Tablet 5 mg (as calcium)

Oral

30

11

 

Tablet 10 mg (as calcium)

Oral

30

11

 

Tablet 20 mg (as calcium)

Oral

30

11

 

Tablet 40 mg (as calcium)

Oral

30

11